Terms: = Prostate cancer AND ACSL3, PRO2194, 2181, ENSG00000123983, O95573, FACL3, ACS3
20 results:
1. Comparison of Magnetic Resonance Imaging-Based Risk Calculators to Predict prostate cancer Risk.
Patel HD; Remmers S; Ellis JL; Li EV; Roobol MJ; Fang AM; Davik P; Rais-Bahrami S; Murphy AB; Ross AE; Gupta GN
JAMA Netw Open; 2024 Mar; 7(3):e241516. PubMed ID: 38451522
[TBL] [Abstract] [Full Text] [Related]
2. An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancer.
Zhu WZ; Feng DC; Xiong Q; Shi X; Zhang FC; Wei Q; Yang L
Asian J Androl; 2023; 25(2):208-216. PubMed ID: 36412461
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of maintenance of the common androgen deprivation therapy with the new antiandrogen therapy in patients with castration-resistant prostate cancer: a systematic review.
Salgado CM; Garcia-Perdomo HA; Reis LO
Int Urol Nephrol; 2022 Jun; 54(6):1187-1192. PubMed ID: 35384583
[TBL] [Abstract] [Full Text] [Related]
4. Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent prostate cancer.
Ma Y; Zhang X; Alsaidan OA; Yang X; Sulejmani E; Zha J; Beharry Z; Huang H; Bartlett M; Lewis Z; Cai H
Mol Cancer Res; 2021 Jan; 19(1):124-135. PubMed ID: 33077484
[TBL] [Abstract] [Full Text] [Related]
5. Integrative Genomic Analysis of OCT1 Reveals Coordinated Regulation of Androgen Receptor in Advanced prostate cancer.
Takayama KI; Suzuki Y; Yamamoto S; Obinata D; Takahashi S; Inoue S
Endocrinology; 2019 Feb; 160(2):463-472. PubMed ID: 30649323
[TBL] [Abstract] [Full Text] [Related]
6. Pathologically Node-Positive prostate Carcinoma - Prevalence, Pattern of Care and Outcome From a Population-Based Study.
Roy S; Sia M; Tyldesley S; Bahl G
Clin Oncol (R Coll Radiol); 2019 Feb; 31(2):91-98. PubMed ID: 30389262
[TBL] [Abstract] [Full Text] [Related]
7. acsl3 promotes intratumoral steroidogenesis in prostate cancer cells.
Migita T; Takayama KI; Urano T; Obinata D; Ikeda K; Soga T; Takahashi S; Inoue S
Cancer Sci; 2017 Oct; 108(10):2011-2021. PubMed ID: 28771887
[TBL] [Abstract] [Full Text] [Related]
8. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
[TBL] [Abstract] [Full Text] [Related]
9. Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.
Obinata D; Takayama K; Fujiwara K; Suzuki T; Tsutsumi S; Fukuda N; Nagase H; Fujimura T; Urano T; Homma Y; Aburatani H; Takahashi S; Inoue S
Oncogene; 2016 Dec; 35(49):6350-6358. PubMed ID: 27270436
[TBL] [Abstract] [Full Text] [Related]
10. Acknowledging unreported problems with active surveillance for prostate cancer: a prospective single-centre observational study.
Hefermehl LJ; Disteldorf D; Lehmann K
BMJ Open; 2016 Feb; 6(2):e010191. PubMed ID: 26888730
[TBL] [Abstract] [Full Text] [Related]
11. May non-metastatic clinically localized castration-resistant prostate cancer after primary androgen ablation benefit from salvage prostate radiotherapy?
Botticella A; Guarneri A; Filippi AR; Levra NG; Munoz F; Ragona R; Gontero P; Ricardi U
J Cancer Res Clin Oncol; 2013 Nov; 139(11):1955-60. PubMed ID: 24057645
[TBL] [Abstract] [Full Text] [Related]
12. Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.
Marques RB; Dits NF; Erkens-Schulze S; van Ijcken WF; van Weerden WM; Jenster G
PLoS One; 2011; 6(8):e23144. PubMed ID: 21829708
[TBL] [Abstract] [Full Text] [Related]
13. Expression and vitamin D3 regulation of long-chain fatty-acid-CoA ligase 3 in human prostate cancer cells.
Qiao S; Tuohimaa P
Prostaglandins Leukot Essent Fatty Acids; 2011; 84(1-2):19-23. PubMed ID: 21041072
[TBL] [Abstract] [Full Text] [Related]
14. [prostate cancer management and factors associated with radical prostatectomy in France in 2001].
Jegu J; Tretarre B; Velten M; Guizard AV; Danzon A; Buemi A; Colonna M; Kadi-Hanifi AM; Ganry O; Molinie F; Bara S; Rebillard X; Grosclaude P
Prog Urol; 2010 Jan; 20(1):56-64. PubMed ID: 20123529
[TBL] [Abstract] [Full Text] [Related]
15. Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer.
Attard G; Clark J; Ambroisine L; Mills IG; Fisher G; Flohr P; Reid A; Edwards S; Kovacs G; Berney D; Foster C; Massie CE; Fletcher A; De Bono JS; Scardino P; Cuzick J; Cooper CS;
Br J Cancer; 2008 Jul; 99(2):314-20. PubMed ID: 18594527
[TBL] [Abstract] [Full Text] [Related]
16. Learning amid controversy: prostate cancer knowledge and screening practices among US medical students.
Werny DM; Saraiya M; Carrera J; Coughlin SS; Frank E
J Cancer Educ; 2008; 23(2):108-13. PubMed ID: 18569246
[TBL] [Abstract] [Full Text] [Related]
17. Vitamin D3 inhibits fatty acid synthase expression by stimulating the expression of long-chain fatty-acid-CoA ligase 3 in prostate cancer cells.
Qiao S; Tuohimaa P
FEBS Lett; 2004 Nov; 577(3):451-4. PubMed ID: 15556626
[TBL] [Abstract] [Full Text] [Related]
18. The role of long-chain fatty-acid-CoA ligase 3 in vitamin D3 and androgen control of prostate cancer LNCaP cell growth.
Qiao S; Tuohimaa P
Biochem Biophys Res Commun; 2004 Jun; 319(2):358-68. PubMed ID: 15178414
[TBL] [Abstract] [Full Text] [Related]
19. Erectile function and quality of life after interstitial radiation therapy for prostate cancer.
Sánchez-Ortiz RF; Broderick GA; Rovner ES; Wein AJ; Whittington R; Malkowicz SB
Int J Impot Res; 2000 Sep; 12 Suppl 3():S18-24. PubMed ID: 11002395
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods.
Hall GS; Kramer CE; Epstein JI
Am J Surg Pathol; 1992 Apr; 16(4):315-24. PubMed ID: 1373577
[TBL] [Abstract] [Full Text] [Related]
